BiotechTube
Home/Roar Biomedical/Robert W. Brocia
RW

Robert W. Brocia

Chief Executive Officer

Roar Biomedical

Therapeutic Areas

CardiovascularMetabolic Disease

Roar Biomedical Pipeline

DrugIndicationPhase
CETP Activity AssaysCardiovascular Disease (Pharmacodynamic Biomarker)Commercial
LCAT Activity AssaysCardiovascular/Metabolic Disease (Pharmacodynamic Biomarker)Commercial
Co-branding & DistributionResearch ToolsCommercial

Leadership Team at Roar Biomedical

MD
Marie Dagata
President
View full Roar Biomedical profile